BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015

Jul 22, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-07-20

Reporting Person: Ajer Jeffrey Robert (SVP, Chief Commercial Of)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-20	Common Stock	M	3000	$63.1	Acquired	38605	Direct
2015-07-20	Common Stock	S	3000	$150.00	Disposed	35605	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-20	Stock Option (right to buy) Common Stock	$63.1	M	3000	Disposed	2024-06-03	Common Stock (3000)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed Mayy 11, 2015

F2: All shares sold at the same price

F3: Original option grant vests 6/48ths on December 4, 2014 and 1/48th on the 4th fay of ever month thereafter.

F4: Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transactions.